Q4 2018 Holdings
Filed 2019-02-14 | 35 holdings | $323.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $124.0M | 1,980,000 | 38.3% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $115.8M | 1,360,000 | 35.8% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $82.6M | 860,000 | 25.5% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $252.8K | 17,714,461 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $203.5K | 4,798,101 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $139.1K | 1,275,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $97.0K | 10,125,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $90.8K | 10,261,039 | 0.0% |
| Horizon Pharma PLC | Common | G4617B105 | $85.0K | 4,350,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $75.9K | 5,575,000 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $72.0K | 1,975,000 | 0.0% |
| Loxo Oncology Inc | Common | 548862101 | $45.5K | 325,000 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $41.3K | 1,750,000 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | Common | 019770106 | $27.8K | 1,128,584 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $25.4K | 225,000 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $22.6K | 1,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | Common | 88322Q108 | $19.5K | 4,750,000 | 0.0% |
| Intec Pharma LTD | Common | M53644106 | $18.9K | 2,500,000 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $17.5K | 4,725,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | Common | 695127100 | $17.2K | 400,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $15.1K | 2,400,000 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $14.4K | 350,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $13.0K | 380,000 | 0.0% |
| Establishment Labs Holdings Inc(ESTA) | Common | G31249108 | $13.0K | 475,000 | 0.0% |
| Teligent Inc | Common | 87960W104 | $7.3K | 5,300,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $7.1K | 1,105,999 | 0.0% |
| Kodiak Sciences Inc(KOD) | Common | 50015M109 | $6.4K | 902,200 | 0.0% |
| Y Mabs Therapeutics Inc(YMABUSD) | Common | 984241109 | $6.3K | 310,000 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $4.5K | 6,240,000 | 0.0% |
| Proteostasis Therapeutics Inc | Common | 74373B109 | $4.2K | 1,300,000 | 0.0% |
| Acer Therapeutics Inc(OPXAEUR) | Common | 00444P108 | $3.0K | 150,000 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $2.5K | $6,000,000 | 0.0% |
| Spdr Series Trust - S&P Biotech(XBI)Call | ETF | 78464A870 | $1.4K | 500,000 | 0.0% |
| Outlook Therapeutics Inc | Common | 69012T107 | $340 | 680,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX)Call | Common | 64125C109 | $15 | 50,000 | 0.0% |